Tissue factor pathway inhibitor deficiency enhances neointimal proliferation and formation in a murine model of vascular remodelling

Ripudamanjit Singh; Shuchong Pan; Cheryl S. Mueske; Tyra A. Witt; Laurel S. Kleppe; Timothy E. Peterson; Noel M. Caplice; Robert D. Simari

doi:10.1055/s-0037-1613582

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2003; 89(04): 747-751
DOI: 10.1055/s-0037-1613582

Vascular Development and Vessel Remodelling

Schattauer GmbH

Tissue factor pathway inhibitor deficiency enhances neointimal proliferation and formation in a murine model of vascular remodelling

Ripudamanjit Singh

¹Department of Internal Medicine and Cardiovascular Disease, Department of Biochemistry and Molecular Biology, Molecular Medicine Program, Mayo Clinic and Foundation, Rochester, Minnesota, USA

,

Shuchong Pan

¹Department of Internal Medicine and Cardiovascular Disease, Department of Biochemistry and Molecular Biology, Molecular Medicine Program, Mayo Clinic and Foundation, Rochester, Minnesota, USA

,

Cheryl S. Mueske

¹Department of Internal Medicine and Cardiovascular Disease, Department of Biochemistry and Molecular Biology, Molecular Medicine Program, Mayo Clinic and Foundation, Rochester, Minnesota, USA

,

Tyra A. Witt

¹Department of Internal Medicine and Cardiovascular Disease, Department of Biochemistry and Molecular Biology, Molecular Medicine Program, Mayo Clinic and Foundation, Rochester, Minnesota, USA

,

Laurel S. Kleppe

¹Department of Internal Medicine and Cardiovascular Disease, Department of Biochemistry and Molecular Biology, Molecular Medicine Program, Mayo Clinic and Foundation, Rochester, Minnesota, USA

,

Timothy E. Peterson

¹Department of Internal Medicine and Cardiovascular Disease, Department of Biochemistry and Molecular Biology, Molecular Medicine Program, Mayo Clinic and Foundation, Rochester, Minnesota, USA

,

Noel M. Caplice

¹Department of Internal Medicine and Cardiovascular Disease, Department of Biochemistry and Molecular Biology, Molecular Medicine Program, Mayo Clinic and Foundation, Rochester, Minnesota, USA

,

Robert D. Simari

¹Department of Internal Medicine and Cardiovascular Disease, Department of Biochemistry and Molecular Biology, Molecular Medicine Program, Mayo Clinic and Foundation, Rochester, Minnesota, USA

› Institutsangaben

Abstract

Summary

Tissue factor (TF) is a small-molecular-weight glycoprotein that initiates the extrinsic coagulation pathway but may have important noncoagulation vascular functions as well. Tissue factor pathway inhibitor (TFPI) is a major physiological inhibitor of TF-initiated coagulation. Enhancement of vascular TFPI either by overexpression using gene transfer or delivery of protein to the vessel has been shown to reduce neointimal formation. However, the inherent role of TFPI in this process has not been defined. To do so, we utilized a murine model of vascular remodeling using flow cessation in mice, which are heterozygous for a genetic deletion of the first Kunitz domain of TFPI or wild type littermates. The heterozygotic mice had 50% of wild type TFPI activity in plasma as well as vascular homogenates. To study the effect of TFPI deficiency on neointimal formation, age matched TFPI_K1+/- and wildtype littermates underwent unilateral common carotid artery ligation. Mice were sacrificed at 4 weeks and the ligated carotid arteries were analyzed. There was a significantly greater neointima to media ratio and less luminal area in the TFPI_K1+/- mice compared to their TFPI_K1+/+ littermates. The proliferative index of intimal cells in TFPI_K1+/-mice at 1 week was significantly higher compared to TFPI_K1+/+mice. We conclude that TFPI deficiency enhances neointimal formation and proliferation associated with flow cessation. This suggests that TFPI may regulate vascular remodeling primarily through modulation of neointimal formation.

Theme paper: Part of this paper was originally presented at the joint meetings of the 16th International Congress of the International Society of Fibrinolysis and Proteolysis (ISFP) and the 17th International Fibrinogen Workshop of the International Fibrinogen Research Society (IFRS) held in Munich, Germany, September, 2002.

Keywords

Thrombosis - remodeling - neointima - tissue factor - inhibitors

Volltext

Referenzen

References
1 Rappaport S, Rao L. Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb 1992; 12 (10) 1111-21.
2 Nemerson Y. Tissue factor and hemostasis. Blood 1988; 71: 1-8.
3 Speidel C, Eisenberg P, Ruf W, Edgington T, Abendschein D. Tissue factor mediates prolonged procoagulant activity on the luminal surface of balloon-injured aortas in rabbits. Circulation 1995; 92: 3323-30.
4 Speidel C, Thornton J, Meng Y, Eisenberg P, Edgington T, Adendschein D. Procoagulant activity on injured arteries and associated thrombi is mediated primarily by the complex of tissue factor and factor VIIa. Coron Artery Dis 1996; 7: 57-62.
5 Pawashe A, Golino P, Ambrosio G, Migliaccio F, Ragni M, Pascucci I, Chiariello M, Bach R, Garen A, Konigsberg W. A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries. Circ Res 1994; 74: 56-63.
6 Toschi V, Gallo R, Lettino M, Fallon J, Gertz S, Fernandez-Ortiz A, Chesebro J, Badimon L, Nemerson Y, Fuster V, Badimon J. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 1997; 95: 594-9.
7 Wilcox J, Smith K, Schwartz S, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci, USA 1989; 86: 2839-43.
8 Annex B, Denning S, Channon K, Sketch Jr. M, Stack R, Morrissey J, Peters K. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation 1995; 91 (03) 619-22.
9 Ragni M, Golino P, Cirillo P, Scognamiglio A, Piro O, Esposito N, Battaglia C, Botticella F, Ponticelli P, Ramunno L, Chiariello M. Endogenous tissue factor pathway inhibitor modulates thrombus formation in an in vivomodel of rabbit carotid artery stenosis and endothelial injury. Circulation 2000; 102: 113-7.
10 Bajaj M, Kuppuswamy M, Saito H, Spitzer S, Bajaj S. Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis. Proc Natl Acad Sci, USA 1990; 87 (22) 8869-73.
11 Lindhout T, Blezer R, Schoen P, Nordfang O, Reutelingsperger C, Hemker H. Activation of factor X and its regulation by tissue factor pathway inhibitor in small-diameter capillaries lined with human endothelial cells. Blood 1992; 79 (11) 2909-16.
12 Werling R, Zacharski L, Kisiel W, Bajaj S, Memoli V, Rousseau S. Distribution of tissue factor pathway inhibitor in normal and malignant human tissues. Thromb Haemost 1993; 69 (04) 366-9.
13 van der Logt C, Dirven R, Reitsma P, Bertina R. Expression of tissue factor and tissue factor pathway inhibitor in monocytes in response to bacterial lipopolysaccharide and phorbolester. Blood Coagul Fibrinolysis 1994; 5: 211-20.
14 Caplice NM, Mueske CS, Kleppe LS, Peterson TE, Broze GJ, Simari RD. Expression of tissue factor pathway inhibitor in vascular smooth muscle cells and its regulation by growth factors. Circ Res 1998; 83: 1264-70.
15 Singh R, Pan S, Mueske CS, Witt T, Kleppe LS, Peterson TE, Slobodova A, Chang J-Y, Caplice NM, Simari RD. Role for tissue factor pathway in murine model of vascular remodeling. Circ Res 2001; 89: 71-6.
16 Zoldhelyi P, Chen Z-Q, Shelat H, McNatt J, Willerson J. Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries. Proc Natl Acad Sci, USA 2001; 98: 4078-83.
17 Atsuchi N, Nishida T, Marutsuka K, Asada Y, Kamikubo Y, Takeshita A, Ueno H. Combination of a brief irrigation with tissue factor pathway inhibitor (TFPI) and adenovirus-mediated local TFPI gene transfer additively reduces neointima formation in balloon-injured rabbit carotid arteries. Circulation 2001; 103: 570-5.
18 Huang ZF, Higuchi D, Lasky N, Broze Jr GJ. Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood 1997; 90: 944-51.
19 Kumar A, Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arteriolscler Thromb Vasc Biol 1997; 17: 2238-44.
20 Nishida T, Ueno H, Atsuchi N, Kawano R, Asada Y, Nakahara Y, Kamikubo Y, Takeshita A, Yasui H. Adenovirus-mediated local expression of human tissue factor pathway inhibitor eliminates shear stress-induced recurrent thrombosis in the injured carotid artery of the rabbit. Circ Res 1999; 84: 1446-52.
21 Oltrona L, Speidel CM, Recchia D, Wickline SA, Eisenberg PR, Abendschein DR. Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs. Circulation 1997; 96: 646-52.
22 Jang Y, Guzman L, Lincoff A, Gottsauner-Wolf M, Forudi F, Hart C, Courtman D, Ezban M, Ellis S, Topol E. Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model. Circulation 1995; 92 (10) 3041-50.
23 Westrick R, Bodary P, Xu Z, Shen Y-C, Broze G, Eizman D. Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice. Circulation 2001; 103: 3044-6.